Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Blastocarb
2. Carboplat
3. Carboplatin
4. Carbosin
5. Carbotec
6. Cbdca
7. Cis-diammine(cyclobutanedicarboxylato)platinum Ii
8. Ercar
9. Jm 8
10. Jm-8
11. Jm8
12. Nealorin
13. Neocarbo
14. Nsc 241240
15. Nsc-241240
16. Nsc241240
17. Paraplatin
18. Paraplatine
19. Platinwas
20. Ribocarbo
1. Paraplatin
2. Cbdca
3. Jm-8
4. Cis-diammine(1,1-cyclobutanedicarboxylato)platinum
5. Nsc 241240
6. Nsc-241240
7. Carboplatin [usan]
8. Bg3f62ond5
9. Cis-diammine(1,1-cyclobutanedicarboxylato) Platinum
10. Platinum, Diammine [1,1-cyclobutane-dicarboxylato(2-)-0,0']-,(sp-4-2)
11. Nsc-201345
12. Carboplatin [mi]
13. Carboplatin [inn]
14. Carboplatin [jan]
15. Carboplatin [hsdb]
16. Carboplatin [vandf]
17. Carboplatin [mart.]
18. Carboplatin [usp-rs]
19. Carboplatin [who-dd]
20. Cis-diamine(1,1-cyclobutanedicarboxylato)platinum(ii)
21. Carboplatin [ep Impurity]
22. Carboplatin [orange Book]
23. Carboplatin [ep Monograph]
24. Carboplatin [usp Impurity]
25. Carboplatin [usp Monograph]
26. Amy33401
27. S1215
28. Akos037515487
29. Ccg-268304
30. Ab01568249_01
31. Q415588
32. W-106301
33. Platinum, Diamine(1,1-cyclobutanedicarboxylato (2-)-o,o')-, (sp-4-2)-
Molecular Weight | 371.25 g/mol |
---|---|
Molecular Formula | C6H12N2O4Pt |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 0 |
Exact Mass | 371.044501 g/mol |
Monoisotopic Mass | 371.044501 g/mol |
Topological Polar Surface Area | 82.3 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 153 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
1 of 2 | |
---|---|
Drug Name | Carboplatin |
PubMed Health | Carboplatin (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | Carboplatin injection is supplied as a sterile, pyrogen-free, 10 mg/mL aqueous solution of carboplatin. Carboplatin is a platinum coordination compound. The chemical name for carboplatin is platinum, diammine [1,1-cyclobutane-dicarboxylato(2-)-0,0... |
Active Ingredient | Carboplatin |
Dosage Form | Injectable |
Route | Iv (infusion) |
Strength | 450mg/45ml (10mg/ml); 150mg/15ml (10mg/ml); 600mg/60ml (10mg/ml); 1gm/100ml (10mg/ml); 50mg/5ml (10mg/ml) |
Market Status | Prescription |
Company | Pliva Lachema; Actavis Elizabeth; Fresenius Kabi Usa; Hospira; Mylan Institutional; Fresenius Kabi Oncol; Ebewe Pharma; Pharmachemie Bv; Onco Therapies; Teva Pharms Usa; Eurohlth Intl; Sagent Pharms; Cipla; Sun Pharma Global; Akorn |
2 of 2 | |
---|---|
Drug Name | Carboplatin |
PubMed Health | Carboplatin (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | Carboplatin injection is supplied as a sterile, pyrogen-free, 10 mg/mL aqueous solution of carboplatin. Carboplatin is a platinum coordination compound. The chemical name for carboplatin is platinum, diammine [1,1-cyclobutane-dicarboxylato(2-)-0,0... |
Active Ingredient | Carboplatin |
Dosage Form | Injectable |
Route | Iv (infusion) |
Strength | 450mg/45ml (10mg/ml); 150mg/15ml (10mg/ml); 600mg/60ml (10mg/ml); 1gm/100ml (10mg/ml); 50mg/5ml (10mg/ml) |
Market Status | Prescription |
Company | Pliva Lachema; Actavis Elizabeth; Fresenius Kabi Usa; Hospira; Mylan Institutional; Fresenius Kabi Oncol; Ebewe Pharma; Pharmachemie Bv; Onco Therapies; Teva Pharms Usa; Eurohlth Intl; Sagent Pharms; Cipla; Sun Pharma Global; Akorn |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Cross-Linking Reagents
Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
47
PharmaCompass offers a list of Carboplatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carboplatin manufacturer or Carboplatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carboplatin manufacturer or Carboplatin supplier.
PharmaCompass also assists you with knowing the Carboplatin API Price utilized in the formulation of products. Carboplatin API Price is not always fixed or binding as the Carboplatin Price is obtained through a variety of data sources. The Carboplatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pharmachemie Brand of Carboplatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pharmachemie Brand of Carboplatin, including repackagers and relabelers. The FDA regulates Pharmachemie Brand of Carboplatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pharmachemie Brand of Carboplatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pharmachemie Brand of Carboplatin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pharmachemie Brand of Carboplatin supplier is an individual or a company that provides Pharmachemie Brand of Carboplatin active pharmaceutical ingredient (API) or Pharmachemie Brand of Carboplatin finished formulations upon request. The Pharmachemie Brand of Carboplatin suppliers may include Pharmachemie Brand of Carboplatin API manufacturers, exporters, distributors and traders.
click here to find a list of Pharmachemie Brand of Carboplatin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pharmachemie Brand of Carboplatin DMF (Drug Master File) is a document detailing the whole manufacturing process of Pharmachemie Brand of Carboplatin active pharmaceutical ingredient (API) in detail. Different forms of Pharmachemie Brand of Carboplatin DMFs exist exist since differing nations have different regulations, such as Pharmachemie Brand of Carboplatin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pharmachemie Brand of Carboplatin DMF submitted to regulatory agencies in the US is known as a USDMF. Pharmachemie Brand of Carboplatin USDMF includes data on Pharmachemie Brand of Carboplatin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pharmachemie Brand of Carboplatin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pharmachemie Brand of Carboplatin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pharmachemie Brand of Carboplatin Drug Master File in Japan (Pharmachemie Brand of Carboplatin JDMF) empowers Pharmachemie Brand of Carboplatin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pharmachemie Brand of Carboplatin JDMF during the approval evaluation for pharmaceutical products. At the time of Pharmachemie Brand of Carboplatin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pharmachemie Brand of Carboplatin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pharmachemie Brand of Carboplatin Drug Master File in Korea (Pharmachemie Brand of Carboplatin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pharmachemie Brand of Carboplatin. The MFDS reviews the Pharmachemie Brand of Carboplatin KDMF as part of the drug registration process and uses the information provided in the Pharmachemie Brand of Carboplatin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pharmachemie Brand of Carboplatin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pharmachemie Brand of Carboplatin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pharmachemie Brand of Carboplatin suppliers with KDMF on PharmaCompass.
A Pharmachemie Brand of Carboplatin CEP of the European Pharmacopoeia monograph is often referred to as a Pharmachemie Brand of Carboplatin Certificate of Suitability (COS). The purpose of a Pharmachemie Brand of Carboplatin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pharmachemie Brand of Carboplatin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pharmachemie Brand of Carboplatin to their clients by showing that a Pharmachemie Brand of Carboplatin CEP has been issued for it. The manufacturer submits a Pharmachemie Brand of Carboplatin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pharmachemie Brand of Carboplatin CEP holder for the record. Additionally, the data presented in the Pharmachemie Brand of Carboplatin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pharmachemie Brand of Carboplatin DMF.
A Pharmachemie Brand of Carboplatin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pharmachemie Brand of Carboplatin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pharmachemie Brand of Carboplatin suppliers with CEP (COS) on PharmaCompass.
A Pharmachemie Brand of Carboplatin written confirmation (Pharmachemie Brand of Carboplatin WC) is an official document issued by a regulatory agency to a Pharmachemie Brand of Carboplatin manufacturer, verifying that the manufacturing facility of a Pharmachemie Brand of Carboplatin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pharmachemie Brand of Carboplatin APIs or Pharmachemie Brand of Carboplatin finished pharmaceutical products to another nation, regulatory agencies frequently require a Pharmachemie Brand of Carboplatin WC (written confirmation) as part of the regulatory process.
click here to find a list of Pharmachemie Brand of Carboplatin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pharmachemie Brand of Carboplatin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pharmachemie Brand of Carboplatin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pharmachemie Brand of Carboplatin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pharmachemie Brand of Carboplatin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pharmachemie Brand of Carboplatin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pharmachemie Brand of Carboplatin suppliers with NDC on PharmaCompass.
Pharmachemie Brand of Carboplatin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pharmachemie Brand of Carboplatin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pharmachemie Brand of Carboplatin GMP manufacturer or Pharmachemie Brand of Carboplatin GMP API supplier for your needs.
A Pharmachemie Brand of Carboplatin CoA (Certificate of Analysis) is a formal document that attests to Pharmachemie Brand of Carboplatin's compliance with Pharmachemie Brand of Carboplatin specifications and serves as a tool for batch-level quality control.
Pharmachemie Brand of Carboplatin CoA mostly includes findings from lab analyses of a specific batch. For each Pharmachemie Brand of Carboplatin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pharmachemie Brand of Carboplatin may be tested according to a variety of international standards, such as European Pharmacopoeia (Pharmachemie Brand of Carboplatin EP), Pharmachemie Brand of Carboplatin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pharmachemie Brand of Carboplatin USP).